Edition:
United States

Helius Medical Technologies Inc (HSM.TO)

HSM.TO on Toronto Stock Exchange

10.75CAD
10:35am EST
Change (% chg)

$0.15 (+1.42%)
Prev Close
$10.60
Open
$10.71
Day's High
$10.83
Day's Low
$10.70
Volume
10,600
Avg. Vol
16,456
52-wk High
$17.20
52-wk Low
$9.40

Latest Key Developments (Source: Significant Developments)

Helius Medical Technologies provides clarification on clinical trial results
Friday, 17 Nov 2017 08:43am EST 

Nov 17 (Reuters) - Helius Medical Technologies Inc :Helius Medical Technologies provides clarification on clinical trial results and confirms intention to include traumatic brain injury (TBI) registrational and long-term treatment trial data to support application for clearance by the FDA.  Full Article

Helius Medical Technologies announces positive results from its registrational clinical trial for traumatic brain injury
Thursday, 9 Nov 2017 06:00am EST 

Nov 9 (Reuters) - Helius Medical Technologies Inc :Helius Medical Technologies announces positive results from its registrational clinical trial for traumatic brain injury (TBI).  Full Article

Helius Medical Technologies files for mixed shelf of up to $100 mln - SEC filing
Friday, 23 Dec 2016 06:22am EST 

Helius Medical Technologies Inc : Files for mixed shelf of up to $100 million - SEC filing .May use a portion of net proceeds to invest,acquire businesses,technologies we believe are complementary.  Full Article

Helius Medical reached full enrollment in tactile communication and neurorehabilitation laboratory clinical trial
Monday, 5 Dec 2016 09:00am EST 

Helius Medical Technologies Inc : Full enrollment reached in tactile communication and neurorehabilitation laboratory clinical trial .Helius Medical Technologies Inc says based on treatment timeline, expected completion date of 44-subject study for PoNS therapy is late May, 2017.  Full Article

No consensus analysis data available.